| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6116c6818e82b1afbddedc2323735364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c55f92637b985bfa33d1f0ff2ed499a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5e8ebad91e40cea9b8189b2d6827182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f281a4c4f7a6107946afb24ce08667b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-445 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 |
| filingDate |
2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03698ca6442bb4d86aa178faba968087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8cb906e8fb3850e1018cc4163b41c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dea63982bc7f3e57dc8193fa66ef20e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356b2df1c1b44fbb7a8ca57618822fdf |
| publicationDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006127314-A1 |
| titleOfInvention |
Method and arrangement for producing contrast agent for magnetic resonance imaging |
| abstract |
The present invention relates to an arrangement and a method for providing contrast agent for e.g. MRI (Magnetic Resonance Imaging) and NMR (Nuclear Magnetic Resonance) applications. The method according to the invention comprises the steps of obtaining ( 100 ) a solution in a solvent of a hydrogenatable, unsaturated substrate compound and a catalyst for the hydrogenation of a substrate compound, hydrogenating ( 105 ) the substrate with hydrogen gas (H 2 ) enriched in para-hydrogen (p- 1 H 2 ) to form a hydrogenated contrast agent and exposing ( 110: 705 ) the contrast agent to a magnetic field cycling profile adapted for enhancing the contrasting effects of the contrast agent. The magnetic field cycling profile comprises an initial decrease of the magnetic field followed by at least one increase of the magnetic field, which increase should be arranged as to give a non-adiabatic (diabatic) remagnetisation of the contrast agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020142157-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017009856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210102450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102565146-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11366186-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11493584-B2 |
| priorityDate |
2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |